Crucially, this observation was made by comparing the transcriptional profiles of MET-addicted cancers expressing either METΔexon14 or exhibiting high-grade amplification of the wild type MET gene, suggesting divergent mechanisms underpinning MET-driven tumourigenesis. Here, MET is linked to cancer.